Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study)

Rubio-Valera, Maria, Beneitez, Imma, Peñarrubia-María, María Teresa, Luciano, Juan V., Mendive, Juan M., McCrone, Paul, Knapp, Martin ORCID: 0000-0003-1427-0215, Sabés-Figuera, Ramon, Kocyan, Katarzyna, García-Campayo, Javier and Serrano-Blanco, Antoni (2015) Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study). BMC Psychiatry, 15 (1). p. 63. ISSN 1471-244X

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (810kB) | Preview

• Author

Abstract

Background Clinical practice guidelines for the treatment of major depressive disorder (MDD) recommend antidepressants for patients with moderate-severe depression and active monitoring for patients with mild-moderate symptoms. The feasibility and efficiency of active monitoring has not been proven conclusively. The aim of this study is to evaluate the cost-effectiveness of active monitoring in comparison to antidepressants for primary care patients with mild-moderate MDD. Methods/Design This is a 12-month follow-up multicenter observational prospective controlled trial. Patients are enrolled in 12 primary care centers in Barcelona (Spain). Eligible patients are adults (≥18 years-old) with a new episode of MDD that sign a written consent to participate. This is a naturalistic study in which general practitioners (GPs) use their professional judgment to allocate patients into active monitoring or antidepressants groups. GPs treat the patients following their clinical criteria. At baseline, GPs complete a questionnaire (sociodemographic/job characteristics, training, attitude towards depression, interest on mental health and participation in communication groups). Patients’ measurements take place at baseline and after six and 12 months. Main outcome measures include severity of depression (PHQ-9), health-related quality of life (EuroQol-5D) and use of healthcare and social care services (Client Service Receipt Inventory). Secondary outcomes include diagnosis of MDD according to DSM-IV diagnostic criteria (SCID-I), disability (WHO-DAS), anxiety (BAI), comorbidities, medication side-effects and beliefs about medicines (BMQ). The analysis will be done according to the intention to treat analysis. Missing data will be imputed using multiple imputation by chained equations. To minimize the bias resulting from the lack of randomization, a propensity score will be used. Incremental effects and costs between groups will be modelled in each of the imputed databases using multivariate generalized linear models and then combined as per Rubin’s rules. Propensity scores will be used to adjust the models. Incremental cost-effectiveness ratios will be calculated by dividing the difference in costs between groups by the difference in effects. To deal with the uncertainty, resampling techniques with bootstrapping will be used and cost-effectiveness planes and cost-effectiveness acceptability curves will be constructed. A series of sensitivity analyses will be performed. Discussion Given the high burden and costs generated by depressive disorder, it is important that general practitioners treat major depression efficiently. Recent evidence has suggested that antidepressants have low benefits for patients with mild to moderate major depression. For such cases of depression, active monitoring exists as a treatment option, but it is not without difficulties for implementation and its effectiveness and efficiency have not been demonstrated conclusively. The results of the study will provide information on which is the most efficient approach to treat patients with mild to moderate major depression in primary care.

Item Type:	Article
Official URL:	http://www.biomedcentral.com/bmcpsychiatry/
Additional Information:	© 2015 Rubio-Valera et al. © CC-BY-4.0
Divisions:	Social Policy Care Policy and Evaluation Centre
Subjects:	R Medicine > RA Public aspects of medicine R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Date Deposited:	20 Apr 2015 11:40
Last Modified:	01 Nov 2024 04:24
Projects:	FIS PI11-01345, CP14/00087; Madrid, Spain, RD12/0005/0006 & RD12/0005/0008
Funders:	Institute of Health Carlos III, Ministry of Economy and competitiveness, Spain, Research Network Prevention and Health Promotion in Primary Care, European Union ERDF funds
URI:	http://eprints.lse.ac.uk/id/eprint/61636

Actions (login required)

View Item